St. Jude Medical’s primary products are pacemakers and implantable cardioverter defibrillators (ICDs), both of which use electrical impulses to shock irregularly beating hearts back into rhythm. St. Jude, which was founded in 1976, operates through four operating segments: Cardiac Rhythm Management (CRM), Cardiovascular, Atrial Fibrillation, and Neuromodulation. The CRM division, which is focused on developing products to treat irregular heartbeats, brings in the majority of the company’s income (nearly 60%), followed by Cardiovascular (20%), Atrial Fibrillation (14%), and Neuromodulation (7%).
|253 Financial Blvd.|
|Liberty, SC USA 29657|